tiprankstipranks
Trending News
More News >
Torii Pharmaceutical Co (TRXPF)
:TRXPF
US Market

Torii Pharmaceutical Co (TRXPF) Income Statement

Compare
Followers

Torii Pharmaceutical Co Income Statement

Last quarter (Q1 2025), Torii Pharmaceutical Co's total revenue was ¥14.68B, an increase of 9.16% from the same quarter last year. In Q1, Torii Pharmaceutical Co's net income was ¥1.39B. See Torii Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 60.42B¥ 54.64B¥ 48.89B¥ 46.99B¥ 41.70B
Gross Profit
¥ 26.71B¥ 22.76B¥ 23.38B¥ 24.34B¥ 21.74B
Operating Expenses
¥ 19.91B¥ 17.72B¥ 17.84B¥ 19.68B¥ 17.00B
Depreciation and Amortization
¥ 408.00M¥ 459.00M¥ 252.00M¥ 279.00M¥ 461.00M
EBITDA
¥ 7.13B¥ 6.05B¥ 5.97B¥ 5.05B¥ 4.69B
Operating Income
¥ 6.80B¥ 5.04B¥ 5.54B¥ 4.66B¥ 4.74B
Other Income/Expenses
¥ -73.00M¥ 558.00M¥ 182.00M¥ 111.00M¥ -513.00M
Pretax Income
¥ 6.72B¥ 5.59B¥ 5.72B¥ 4.77B¥ 4.22B
Net Income
¥ 5.04B¥ 4.12B¥ 3.94B¥ 3.37B¥ 3.50B
Per Share Metrics
Basic EPS
¥ 179.46¥ 146.57¥ 140.38¥ 120.11¥ 124.47
Diluted EPS
¥ 179.46¥ 146.57¥ 140.38¥ 120.11¥ 124.46
Weighted Average Shares Outstanding
28.11M 28.10M 28.10M 28.09M 28.08M
Weighted Average Shares Outstanding (Diluted)
28.11M 28.10M 28.10M 28.09M 28.08M
Currency in JPY

Torii Pharmaceutical Co Earnings and Revenue History